Correlation Between Aptose Biosciences and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and Sangamo Therapeutics, you can compare the effects of market volatilities on Aptose Biosciences and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and Sangamo Therapeutics.
Diversification Opportunities for Aptose Biosciences and Sangamo Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aptose and Sangamo is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Aptose Biosciences and Sangamo Therapeutics
Given the investment horizon of 90 days Aptose Biosciences is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aptose Biosciences is 1.65 times less risky than Sangamo Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Sangamo Therapeutics on August 31, 2024 and sell it today you would earn a total of 102.00 from holding Sangamo Therapeutics or generate 79.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aptose Biosciences vs. Sangamo Therapeutics
Performance |
| Timeline |
| Aptose Biosciences |
| Sangamo Therapeutics |
Aptose Biosciences and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aptose Biosciences and Sangamo Therapeutics
The main advantage of trading using opposite Aptose Biosciences and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Aptose Biosciences vs. CytomX Therapeutics | Aptose Biosciences vs. Instil Bio | Aptose Biosciences vs. Spero Therapeutics | Aptose Biosciences vs. Assembly Biosciences |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |